JUPITER, Fla. (PRWEB)
September 06, 2022

Advancements with Ted Danson is scheduled to broadcast on Saturday, September 10, 2022, at 8:00 PM ET in primetime on Bloomberg.

Viewers will learn about orphan diseases and will discover how the rarity of these disorders often keeps them from garnering the attention they deserve to gain support and resources for discovering treatments. The segment will explore how the Food Allergy Institute (FAI) –formerly known as the Southern California Food Allergy Institute (SCFAI)– is working to advance treatment discovery at a pace that helps its patients, while building a scalable model of success to accelerate the rate of research discovery for rare and orphan diseases.

Next, the show will educate about Montgomery County, Maryland’s Brookville Smart Energy Bus Depot – the first fully resilient, sustainable Energy as a Service (EaaS) microgrid with EV charging solutions, serving fleet electrification. Audiences will learn about the project, which enables the county’s bus fleet to transition from diesel to electric, advancing the County’s goal to reach net zero carbon emissions by 2035. Spectators will see how the first-of-its-kind EaaS fleet electrification infrastructure project integrates solar photovoltaic canopies, onsite generation, battery energy storage, and electric bus chargers with Schneider Electric’s (Schneider) leading microgrid controls, gear, and energy management software, to ensure the fleet’s continuous operation, regardless of utility outages.

Advancements will also explore how innovations in technology and real-time data are solving real-world problems within healthcare intelligence as it discovers how developments in technology are impacting the entire continuum of care. With a look at Enlitic’s Curie, onlookers will learn how the platform features a host of AI-powered applications to read, report, research, inquire, inform, and automatically standardize and simplify healthcare data.

Finally, the show will discover how the latest developments in AI and smart home technology are allowing anyone to hear any sounds they want, without needing to be physically present. Audiences will learn about Earzz, a smart listening device backed by AI that monitors and recognizes non-speech sounds around the home and will discover how the technology helps busy households, and those who are hard of hearing, recognize and get notified about chosen non-speech sounds around the home.

“We are excited to explore how technology continues to impact communities around the world in this exciting new episode,” said Dustin Schwarz, director of programming for DMG Productions and the Advancements series.

        ###

About Advancements and DMG Productions:

Advancements is an information-based educational television series that explores recent developments taking place across several industries and economies. Shining a light on important issues and topics impacting society today, the series features the cutting-edge improvements, state-of-the-art technologies, and innovative solutions responsible for shaping, molding, and transforming our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming for viewers and networks.

For more information, please visit http://www.AdvancementsTV.com or call 866-496-4065.

Share article on social media or email:

NANISX LLC innovating outpatient spine technologies for Ambulatory Surgery Centers

We are dedicated to support the rise in outpatient spine surgeries by training and equipping Interventional Pain Management doctors, Orthopedic surgeons and Neurosurgeons treating degenerative spinal stenosis and sacroiliac joint pain in ASCs – Kingsley R Chin MD MBA

MALDEN, Ma. (PRWEB)
September 05, 2022

Physician-owned ASCs performing spine procedures were once limited to Orthopedic Surgeons and Neurosurgeons but today there is rapidly more spine procedures being done outpatient by Interventional Pain Management (IPM) doctors such as Anesthesiologists, Physical Medicine and Rehabilitation Physiatrists, and Interventional Radiologists. NANISX LLC will be divided into two ASC divisions: NANISX Pain, focused on interventional pain management, and NANISX Ortho-Neuro. KICVentures Group has recently merged its holdings in three of its portfolio companies into NANISX that are already gaining market adoption in outpatient spine surgery: NanoFUSE Biologics, InSpan and Sacrix

“We are dedicated to support the rise in outpatient spine surgeries by training and equipping Interventional Pain Management doctors, Orthopedic surgeons and Neurosurgeons treating degenerative spinal stenosis and sacroiliac joint (SIJ) pain in ASCs for many years,” says Dr Chin. In addition to being CEO and Founder of the KICVentures Group, Dr. Chin is a board-certified professor of orthopedic spine surgeon who in 2007 moved his medical practice as the Chief of Spine Surgery at the University of Pennsylvania to South Florida where he began his focus on ASC-based spine surgeries. Over the years, he has been expanding research publications, intellectual property and developing LES technologies and teaching physicians techniques to practice in ASCs. It is this firsthand experience that has allowed him to see the demand being generated by physician owners of ASCs who want direct access to technologies that are easy to use, appropriately priced for the ASC to make a profit, and are effective with proven outcomes and low risks of complications.

NANISX LLC will have three leading outpatient spine technologies as a platform to offer the ASC. Sacrix is seeing growing demand as more ASC surgeries are being done to treat sacroiliac joint pain that can go unnoticed in 22% of low back pain sufferers as the source of back and radicular pain. Over 43% of lumbar instrumented spine fusions with pedicle screws will cause adjacent segment pain in the sacroiliac joint requiring surgery. Sacrix pioneered a patented platform of multi-threaded screws and fluted anti-rotational implants including a novel lateral-oblique percutaneous technique that can be done quickly with almost no bleeding through a 1.5 cm incision. Sacrix is experiencing robust demand since the recent announcement that a new T code X034T will be assigned to posterior intra-articular sacroiliac techniques in 2023. This would affect companies and devices doing posterior sacroiliac fusions that can no longer use the CPT 27279 code reserved for lateral fusion transfixing the sacroiliac joint that mainly Sacrix and SI-Bone do among few others. Many IPM doctors who do sacroiliac joint fusions have made the switch to Sacrix and are finding that Sacrix is also an improvement in providing greater fixation, easier technique and improved outcomes with no documented failures or complications.

InSpan’s midline mini-open percutaneous interlaminar-interspinous device (IPD) is seeing growing adoption for treating spinal stenosis and for spinal fusion without the need for pedicle screws or interbody cages. Imagine doing a lumbar spine fusion quickly with no need for expensive navigation or robots to place pedicle screws with much less risk of complications, immediate pain relief and stabilization. NanoFUSE Biologics is the world’s only FDA-approved fiber-based synthetic bioactive glass combined with demineralized bone matrix (DBM) for regenerative bone formation promoting fusion and bone healing. NanoFUSE when combined with an aqueous body fluid forms a 3D porous calcium hydroxyapatite layer for bone formation in as early as 24 hours.

NANISX believes it will take focused dedication to the ASC model to have sustainable adoption and growth but the timing is now. In contrast, the large spine manufacturers are investing more in hospitals anticipating growth with more expensive capital equipment like robots and navigation to place pedicle screws hoping that they can convince ASCs to adopt the same expensive hospital technologies and equipment. Large spine device manufacturers provide devices to hospitals as a commodity and sign exclusive agreements that exclude competition and innovation from smaller companies limiting doctors to use their devices. “KICVentures Group sees a different model for the ASC where the doctors are owners, and therefore empowered to make choices to use what is the most innovative and provide effective outcomes at a price that leaves them a profit by streamlining operational overhead,” says CFO and Co-Founder, Aditya Humad.

NANISX portfolio of technologies are revenue and EBITDA positive and should grow rapidly with the expected addition of a new Chief Executive Officer (CEO) to be announced soon. We have also initiated the listing process to prepare for an IPO with a New York-based advisory firm which includes the search for the right governance and establishing processes to scale and be ready within 12 to 18 months.

INVESTORS

Series A Now open in KICVentures Group.

INVESTOR@kicventures.com.

About NanoFUSE Biologics LLC

NanoFUSE Biologics LLC is privately owned by the KICVentures Group and has a proprietary fiber-based synthetic bioactive glass. NanoFUSE is the only FDA-approved combination of bioactive glass plus DBM and is proven for regenerating bone.

http://www.Nanofusebiologics.com

About INSPAN, LLC

InSpan LLC is privately owned by the KICVentures Group and is focused on advancing the platform of patented interspinous interlaminar fixation technology. The InSpan device has a proven ten-year track record with thousands implanted since FDA clearance in 2010. There are no documented device-related failures or spinous process fractures that have plagued other competitive ISP devices.

https://MyInspan.com/

About SACRIX LLC

Sacrix LLC is privately owned by the KICVentures Group and is focused on revolutionary percutaneous fluoroscopic lateral-oblique sacroiliac joint fusion technologies for the treatment of sacroiliac dysfunction and sacroiliitis. Sacrix developed its patented Sacrofuse threaded implant to be inserted percutaneously and received FDA clearance in 2015. The Gen1 Sacrofuse implant was compared head-to-head with market leader SI bone (SIBN) and found to have a 400% increase in pull-out strength. Sacrix has trained over 200 physicians to perform its revolutionary percutaneous lateral-oblique sacroiliac joint fusion technique safely and effectively through a 1.5 cm incision minimally invasively in outpatient ambulatory surgery centers.

http://www.MySacrix.com

About KICVentures Group

Founded in 2000 makes us the most experienced healthcare investment holding company with the largest portfolio of medical device technologies focused on solutions for less invasive outpatient spine surgery. Our investment strategy is to acquire or invent disruptive technologies using our own capital or partner with private individual investors. This allows us the freedom to make quick and nimble decisions such as when we acquired AxioMed Viscoelastic Disc Technologies while other firms invested in ball-and-socket articulating spacers.

http://www.KICVentures.com

Share article on social media or email:

We’re always in awe of all of the scholarship applicants’ stories, and it’s moving to see their positive spirits, despite the challenges thrown their way in life.

OKLAHOMA CITY (PRWEB)
September 06, 2022

180 Medical, one of America’s leading providers of intermittent catheters and ostomy supplies, is pleased to announce the eight winning recipients of the 180 Medical College Scholarship Program and The 180 Medical Ron Howell Caregiver College Scholarship.

The 180 Medical College Scholarship Program, originally created by founder Todd Brown in 2012, is offered to college students with specific medical conditions including: spinal cord injury, spina bifida, transverse myelitis, neurogenic bladder, and/or an ostomy (ileostomy, urostomy, or colostomy). Since then, 180 Medical has awarded over 60 scholarships to students who’ve experienced challenges and financial burdens that have made paying for college and achieving their goals more difficult.

Todd’s hope in creating the 180 Medical scholarship program was to help eligible students better afford the costs of college so that they might achieve their dreams and “pay it forward” by making a positive impact in the world.

The 180 Medical Ron Howell Caregiver College Scholarship was created in 2020 to honor former 180 Medical President Ron Howell upon his retirement. This scholarship program aims to help college students who are unpaid caregivers to a loved one living with a chronic disability. Because 180 Medical recognizes that these students often face limited financial resources and time, the company created this scholarship program to aid these selfless caregivers in pursuit of their career dreams.

“We’re always in awe of all of the scholarship applicants’ stories, and it’s moving to see their positive spirits, despite the challenges thrown their way in life. So many of them want to use their experiences to go on to help others, and it is an honor to be able to continue our founder Todd Brown’s original vision and help these young students with an education so they can achieve their calling.” – Mark Jassey, Chief Commercial Officer

In 2022, 180 Medical received applications from hopeful students all over the United States, and as always, it was a difficult choice for the committee to begin narrowing down to the final recipients. This year’s finalists have very different backgrounds, and their career goals greatly vary but they all are looking to create a brighter future for themselves and their families.

The seven recipients of the $1,000 180 Medical College Scholarship award are:

o    Lily Wright (Gonzaga University)

o    Laura Haney (Diablo Valley College)

o    Molly Kokoski (Simmons University)

o    Hailey Schmidt (Jefferson College)

o    Taylor Hofmann (Oklahoma State University)

o    Ariana White (University of New Hampshire)

o    Isabella Anderson (Savannah College of Art and Design)

The recipient of the $1,000 180 Medical Ron Howell Caregiver Scholarship award is:

o    Lydia Rose Taylor (Texas Christian University)

180 Medical would like to thank everyone who applied. Every student who sent in their application were qualified and dedicated to their goals. Congratulations to the 2022 scholarship recipients, and to those who did not receive an award this year, they are encouraged to watch for the announcement for the 2022 scholarship awards and apply again in the future.

About 180 Medical:

180 Medical is one of America’s fastest growing home delivery providers of intermittent catheters, ostomy products, and other related urologic disposable medical supplies. Based in Oklahoma City, the company has 20 years of experience in meeting the supply needs of customers with diagnoses such as urinary incontinence, spinal cord injuries, spina bifida, colon cancer, Crohn’s disease, and many other conditions that require catheterization and ostomy supplies. 180 Medical is a subsidiary of Convatec, a leading global medical products and technologies company. For more information, please visit http://www.180medical.com.

Share article on social media or email: